logo
REACH OUT TO US +91 82830 85118 +91 91157 96473 contact@gspharma.tech


Impurity of Elagolix Sodium
Elagolix Sodium Inhouse Impurity 9 / (R)-5-(2-fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-3-(2-phenyl-2-(propan-2-ylideneamino)ethyl)pyrimidine-2,4(1H,3H)-dione
Impurity
GS.07.ELA.39N.png
Product Name Elagolix Sodium Inhouse Impurity 9 / (R)-5-(2-fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-3-(2-phenyl-2-(propan-2-ylideneamino)ethyl)pyrimidine-2,4(1H,3H)-dione
Product Category Impurities, Intermediates
Sub-Category Pharmaceutical Standards, Fine Chemicals, Aromatics, Amines
CAS No 2073864-81-8
Catalog Number GS.07.ELA.39N
Chemical Name/Synonyms (R)-5-(2-fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-3-(2-phenyl-2-(propan-2-ylideneamino)ethyl)pyrimidine-2,4(1H,3H)-dione
Molecular Weight 585.6
Molecular Formula C31H28F5N3O3
Purity NLT 95 %
Applications It is used to treat moderate-to-severe pain associated with endometriosis. By inhibiting GnRH receptors in the pituitary gland, the final drug suppresses ovarian estrogen production, which reduces the growth of endometrial tissue
Inventory Status customized